SEC Company Response from Health Catalyst, (HCAT) — Jul 19, 2019
Health Catalyst, Inc.
Date: July 19, 2019 · CIK: 0001636422 · Accession: 0001628280-19-008823
AI Filing Summary & Sentiment
File numbers found in text: 333-232400
Show Raw Text
CORRESP 1 filename1.htm Document July 19, 2019 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: Jan Woo Mitchell Austin Stephen Krikorian Diane Fritz Re: Health Catalyst, Inc. Registration Statement on Form S-1 (File No. 333-232400) Ladies and Gentlemen: Pursuant to Rule 460 of the General Rules and Regulations under the Securities Act of 1933, as amended, we wish to advise that between July 12, 2019 and the date hereof, approximately 3,238 copies of the Preliminary Prospectus dated July 12, 2019 were distributed to prospective underwriters, institutional investors and prospective dealers in connection with the above-captioned Registration Statement. We wish to advise you that the participating underwriters have informed us that they have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Tuesday, July 23, 2019 or as soon thereafter as practicable. [Signature page follows] Very truly yours, GOLDMAN SACHS & CO. LLC J.P. MORGAN SECURITIES LLC As representatives of the Underwriters By: Goldman Sachs & Co. LLC By: /s/ Gabe Gelman Name: Gabe Gelman Title: Managing Director By: J.P. Morgan Securities LLC By: /s/ Nikul Patel Name: Nikul Patel Title: Executive Director